Dependence and withdrawal
Because MGM-15 is an opioid, regular use produces tolerance and physical dependence, and stopping brings opioid-type withdrawal. There are no published studies measuring MGM-15 withdrawal specifically, so we will not put a day-by-day timeline on it the way we can for kratom and 7-OH. What we can say is grounded in mechanism: because MGM-15 binds the same mu-opioid receptors, withdrawal is expected to follow an opioid course — anxiety, muscle aches, GI symptoms, severe insomnia, and cravings — and the same buprenorphine-based treatment applies.
For the opioid-withdrawal pattern these products tend to follow, our kratom and 7-OH withdrawal timeline is the closest published guide; the 7-OH vs. concentrated products page covers where MGM-15 sits among the newer analogs.
How we treat MGM-15 dependence
The treatment is the same medication-assisted treatment we use for kratom and 7-OH dependence. Buprenorphine products (Suboxone film and tablet, Sublocade injections, Brixadi injections) are FDA-approved for opioid use disorder. Restoration Recovery clinically uses buprenorphine off-label for MGM-15 dependence because MGM-15 is an opioid that binds the same receptors — which is why the medication compresses MGM-15 withdrawal the same way it compresses other opioid withdrawals (per SAMHSA TIP 63). Because there are no MGM-15-specific dosing studies, the doctor individualizes the plan at your first visit based on your reported use and your COWS score.
Your first visit takes 60 to 120 minutes and follows our four-step intake: a DSM-5 substance use disorder assessment plus a COWS (Clinical Opiate Withdrawal Scale) score, then counseling intake, then doctor evaluation, then prescription or injection ordering. Be honest about what you have been using and when your last dose was — clinical decisions depend on accurate information, and anything you share is protected by HIPAA and 42 CFR Part 2, the federal rule that specifically shields addiction-treatment records.
Found one of these products in someone's things?
You do not need a diagnosis or certainty about what it is to call. Our intake team can tell you what the product is and walk through the options — for you or for someone you are worried about.
Call 423-498-2000
Same-week appointments at all four of our clinics
Restoration Recovery operates four outpatient MAT clinics. Each treats MGM-15, kratom, and 7-OH dependence with the same buprenorphine-based protocol. Walk-in appointments are not accepted; all visits are scheduled, and same-week intake is the standard at all four clinics.
- Chattanooga (Mon–Fri) — flagship clinic at 6141 Shallowford Rd, Suite 100. Full MAT formulary including Suboxone, Sublocade, and Brixadi; on-site Intensive Outpatient Programming (IOP); integrated behavioral health; Hepatitis C care.
- Cleveland (Tue/Thu) — 2130 Chambliss Avenue NW, Bradley County. Full MAT formulary including injections; same-week intake possible Tuesday or Thursday.
- Soddy-Daisy (Mon/Wed) — 210 Walmart Drive, Suite 100, northern Hamilton County. Suboxone film and tablet, oral medications for alcohol use disorder, individual counseling, telehealth follow-ups, and Hepatitis C care. If you choose Sublocade or Brixadi, your injections are scheduled at our Chattanooga or Cleveland clinic.
- Ringgold (GA, Friday) — 4962 Battlefield Parkway, Catoosa County. Our Ringgold clinic sees patients on Fridays. Call 423-498-2000 to book.
One number for all four: 423-498-2000.
What it costs in Tennessee
TennCare patient cost is typically $0 (BlueCare, Wellpoint, and UHC Community Plan) via the BESMART preferred-buprenorphine program at our TennCare-enrolled clinics. Commercial insurance is covered by major Tennessee carriers including BCBS, UHC, Aetna, Cigna, and Humana — verify your specific plan. Self-pay is $250 per month flat.
Worried about someone using this?
Whatever its legal status where you are, dependence on MGM-15 responds to the same treatment as any other opioid. Call to talk through what someone is taking and what starting care looks like.
Call 423-498-2000
Is MGM-15 legal?
As of June 2026, MGM-15 is not scheduled under federal law — and neither is 7-OH. The FDA recommended Schedule I classification for concentrated 7-OH in July 2025, and the DEA has not finalized a rule. But "not scheduled" does not mean "legal as a supplement": the FDA treats 7-OH and its analogs sold as supplements or food as unlawful, adulterated products under the Food, Drug, and Cosmetic Act, which is the basis it used for the December 2025 seizures.
States are moving faster, and some are naming the analog directly. Ohio scheduled dihydro-7-OH (MGM-15) by name as a Schedule I controlled substance, effective May 19, 2026. In June 2026, the Missouri Attorney General reached a settlement barring a distributor from selling "dihydro-7-hydroxymitragynine ('MGM-15')" — again, by name.
In Tennessee, Matthew Davenport's Law (HB1649) takes effect July 1, 2026 and bans the retail sale, manufacture, and knowing possession of kratom and 7-OH products. The statute covers "7-hydroxymitragynine and its derivatives," and MGM-15 is a derivative of 7-OH — so the ban is written to reach analogs like it. We are not aware of a Tennessee ruling that names MGM-15 specifically yet. Either way, the law does not restrict treatment: buprenorphine prescribing and clinic access continue unaffected. For the full picture, see our 7-OH scheduling tracker and the Tennessee ban law tracker.
Frequently asked questions
Is MGM-15 the same thing as kratom?
No. MGM-15 does not occur in the kratom plant. It is a laboratory-made opioid built from 7-OH, the concentrated kratom alkaloid. It binds the same mu-opioid receptors as heroin, fentanyl, and oxycodone, and laboratory research describes it as a stronger opioid-receptor agonist than 7-OH. It is sold as a "research" compound or dietary supplement, but clinically it behaves like an opioid.
I found a product like Oxonol or an "MGM-15" supplement. What is it?
It is a semi-synthetic opioid sold as a supplement. Oxonol (Real Botanicals) is a strawberry-flavored chewable whose label lists a "Proprietary Blend (MGM-15, Mitragynine)." Some of these products advertise "0 mg 7-OH," which can read as safer or more legal — but MGM-15 is itself a 7-OH analog in the same opioid class. If someone you know is using one, it is reasonable to treat it as opioid use and talk to a clinic. Our team can tell you what the product is and what the options are. Our guide for families is here.
Can Suboxone or buprenorphine treat MGM-15 dependence?
Yes. Because MGM-15 acts on the same mu-opioid receptors as other opioids, the same buprenorphine-based medication-assisted treatment we use for kratom and 7-OH dependence is the mechanistically appropriate approach. There are no MGM-15-specific dosing or withdrawal studies, so the doctor individualizes care at the first visit.
Is MGM-15 legal in Tennessee?
As of June 2026, MGM-15 is not separately named in Tennessee law. Tennessee's kratom and 7-OH ban takes effect July 1, 2026 and covers "7-hydroxymitragynine and its derivatives." MGM-15 is a derivative of 7-OH, so the ban is written to reach analogs like it, and Ohio has already scheduled it by name. Regardless of legal status, dependence on MGM-15 is treated the same way as any other opioid dependence.
How fast can I start treatment?
Same-week intake is the standard at all four of our clinics. First call to first appointment is typically 1-3 days; the first dose of buprenorphine is often same-day as your first appointment provided your COWS (Clinical Opiate Withdrawal Scale) score is high enough; full stabilization takes 1-2 weeks. Follow-ups during stabilization are typically telehealth.
Restoration Recovery's intake team answers calls Monday through Friday, 9am to 4:30pm Eastern. After hours, leave a message or fill out the callback form and we will respond on the next business day.
